SUPN
NASDAQ · Pharmaceuticals
Supernus Pharmaceuticals Inc
$51.53
-0.75 (-1.43%)
Performance
1D
—
1W
—
1M
—
3M
+0.45%
6M
+11.75%
1Y
+60.28%
YTD
+4.16%
Open$52.46
Previous Close$52.28
Day High$52.59
Day Low$50.36
52W High$59.68
52W Low$29.16
Volume—
Avg Volume937.0K
Market Cap3.03B
P/E Ratio—
EPS$-0.68
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$49.76
Above
SMA 200
$43.00
Above
RSI (14)
59.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+76.3% upside
Current
$51.53
$51.53
Target
$90.83
$90.83
$64.19
$90.83 avg
$118.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 749.94M | 731.51M | 1.12B |
| Net Income | -40,212,204 | -35,301,388 | 218.96M |
| Profit Margin | -5.4% | -5.1% | 19.5% |
| EBITDA | 28.35M | 26.27M | 345.29M |
| Free Cash Flow | — | — | 147.80M |
| Rev Growth | +2.5% | +2.5% | +10.9% |
| Debt/Equity | — | — | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |